Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 1,569 | 3,024 | 768 | 516 | 64 |
| Operating Income | -1,569 | -3,024 | -768 | -516 | -64 |
| Other Income | 44 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -1,525 | -3,024 | -768 | -516 | -64 |
| Net Income Continuous | -1,525 | -3,024 | -768 | -516 | -64 |
| Net Income | $-1,525 | $-3,022 | $-768 | $-516 | $-64 |
| EPS Basic Total Ops | -0.06 | -0.16 | -0.03 | -0.02 | 0.00 |
| EPS Basic Continuous Ops | -0.06 | -0.16 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.06 | -0.16 | -0.03 | -0.02 | 0.00 |
| EPS Diluted Continuous Ops | -0.06 | -0.16 | N/A | N/A | N/A |
| EBITDA(a) | $-1,560 | $-2,695 | $-758 | $-506 | $-64 |